{"_self":{"principle":"Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.","widget":"article_topology","feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","contains":"claims, sources, anecdotes, question_graph slice","slug":"vip-plantar-fasciitis","urls":{"read":"https://miscsubjects.com/api/articles/vip-plantar-fasciitis/topology"},"how_to_use":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","write":null,"imessage":null,"router_tag":null,"proof_chain":[{"step":1,"claim":"Articles are voxel graphs of tiered claims, not prose blobs.","verify":"https://miscsubjects.com/api/articles/constitution"},{"step":2,"claim":"Claims link to hash-chained sources via source_ids.","verify":"https://miscsubjects.com/api/articles/vip-plantar-fasciitis/sources"},{"step":3,"claim":"Ask reads topology; ingest/claim append to ledger.","verify":"https://miscsubjects.com/api/protocol"},{"step":4,"claim":"Models queue growth: populate → collaborate → repair → reflex.","verify":"https://miscsubjects.com/api/protocol/grow"},{"step":5,"claim":"Graph proves its own shape (reflex) and $/claim (yield).","verify":"https://miscsubjects.com/graph.html?layer=reflex"},{"step":6,"claim":"Full feature index + _explain on every API response.","verify":"https://miscsubjects.com/api/articles/system-map"}],"related_features":[{"id":"ask","name":"Ask protocol","what":"Answer only from topology; creates question_node with gaps and ingest_hint.","urls":{"read":"https://miscsubjects.com/api/articles/vip-plantar-fasciitis/prompts","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"graph_topology","name":"Cross-article graph","what":"Merged claims/sources across condition+stack slugs for one question.","urls":{"read":"https://miscsubjects.com/api/articles/vip-plantar-fasciitis/graph-topology?question=..."}},{"id":"question_graph","name":"Question graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output).","urls":{"read":"https://miscsubjects.com/api/articles/vip-plantar-fasciitis/question-graph","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"voxels","name":"Voxel graph","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","urls":{"read":"https://miscsubjects.com/api/articles/vip-plantar-fasciitis/voxels","write":"https://miscsubjects.com/api/protocol/claim"}}],"system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown","not_medical_advice":true},"_explain":{"feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","why":"Every feature is auditable collective intelligence","how":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","model":null,"verifies":null,"urls":{"read":"https://miscsubjects.com/api/articles/vip-plantar-fasciitis/topology"},"imessage":null,"router":null,"related":[{"id":"ask","what":"Answer only from topology; creates question_node with gaps and ingest_hint."},{"id":"graph_topology","what":"Merged claims/sources across condition+stack slugs for one question."},{"id":"question_graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output)."},{"id":"voxels","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance."}],"not_medical_advice":true},"slug":"vip-plantar-fasciitis","title":"VIP for Plantar Fasciitis: Immune Modulation and Tissue Repair Pathways","register":"source_ledger","tags":["peptide","matrix"],"updated_at":"2026-07-17T02:43:26.243Z","body_excerpt":"## What's breaking down if you have Plantar fasciitis\n\nPlantar fasciitis involves degeneration of the plantar fascia, the thick connective tissue band running along the bottom of the foot from heel to toes. Microtears from repetitive overload or sudden strain outpace the tissue's natural repair capacity. This leads to failed healing, local inflammation, and thickened fascia that transmits pain on weight-bearing steps.\n\nThe layers include connective tissue breakdown, immune cell infiltration that sustains low-grade inflammation, and autonomic signaling that can influence local blood flow and pain perception. When breakdown outruns repair, symptoms persist even after initial injury resolves.\n\n## Why VIP might help you\n\nVIP targets the immune and autonomic layer. If your plantar fasciitis involves ongoing immune-driven inflammation that blocks fascia repair, VIP is discussed because it modulates cytokine balance and promotes regulatory responses rather than broadly suppressing signals.\n\n1. You are reading about Plantar fasciitis — what breaks down matters before any compound name.\n2. Therefore for you: If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\n\nVIP binds receptors on immune cells and fibroblasts. In preclinical models of joint inflammation, this shifts the environment toward resolution, allowing connective tissue cells to focus on matrix production instead of chronic defense.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- VIP → immune / autonomic\n\nVIP addresses the immune/autonomic component of fascia degeneration. Other approaches might address mechanical load or direct fibroblast activity, but VIP's role stays specific to modulating the inflammatory milieu that can stall repair.\n\n## What the evidence actually shows\n\nNo human trials test VIP directly for plantar fasciitis (preclinical tier for related conditions; mechanistic tier for general effects). Animal studies in collagen-induced arthritis models (mice) show VIP administration reduces joint swelling, downregulates pro-inflammatory cytokines, and limits bone and cartilage destruction (preclinical tier). One human observational study linked higher VIP serum levels or certain gene variants to lower treatment needs in early rheumatoid arthritis patients (human tier, correlational only).\n\nWound-healing data comes from bronchial epithelial cell cultures where VIP increased proliferation via cAMP pathways (mechanistic tier). No rat or mouse studies examine VIP on plantar fascia specifically.\n\n## What scientists say\n\nReviews note VIP as an endogenous immunomodulator with potential in inflammatory joint diseases, but emphasize lack of clinical translation beyond animal models and call for more human data (mechanistic/speculative tier for plantar fasciitis application). Researchers highlight its ability to promote immune tolerance in autoimmune models without broad suppression.\n\n## What people say on Reddit\n\nAnecdotal reports on peptide forums mention VIP rarely in context of foot or heel issues; discussions center on other peptides for plantar fasciitis or general inflammation. No consistent user experiences tie VIP to fascia healing (anecdotal tier; sparse and indirect).\n\n## What people say on X\n\nSearches yield no relevant posts discussing VIP peptide for plantar fasciitis or heel pain (anecdotal tier; zero direct matches).\n\n## What we do not know\n\nDirect effects on human plantar fascia remain unknown. It is unclear whether systemic or local VIP would reach the foot fascia in meaningful amounts or alter degenerative progression versus symptoms. Weight-loss effects on plantar load (roughly 4 lb reduced compressive force per 1 lb body weight lost) are mechanical and separate from VIP pathways.\n\n## Safety and limits\n\nVIP has been studied in limited human contexts such as sarcoidosis","ranking":"safety-first (interaction_risk/limitations), then quote-gated effective_weight","claims":[{"id":"c1","text":"No direct human trials exist for VIP in plantar fasciitis.","tier":"human","weight":0.8,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":[],"source_status":"unsourced","why_material":"Establishes absence of condition-specific data.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c4","text":"VIP modulates immune responses by shifting cytokine balance toward regulatory profiles in cell and animal models.","tier":"mechanistic","weight":0.3,"section":"Why VIP might help you","slot":null,"interaction_risk":false,"status":"active","source_ids":["web:0"],"source_status":"sourced","why_material":"Explains proposed repair-supporting mechanism via immune layer.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.3,"quote_gated":false},{"id":"c3","text":"Higher VIP levels or related gene variants correlated with reduced treatment intensity in early rheumatoid arthritis patients.","tier":"human","weight":0.8,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["web:36"],"source_status":"sourced","why_material":"Offers limited human correlational evidence in arthritis.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true},{"id":"c2","text":"In mouse collagen-induced arthritis models, VIP reduced joint inflammation and tissue destruction.","tier":"preclinical","weight":0.5,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["web:1"],"source_status":"sourced","why_material":"Provides closest preclinical analog for inflammatory joint/tissue conditions.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true}],"sources":[{"id":"web:0","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6982157/","title":"A Clinical Approach for the Use of VIP Axis in Inflammatory and Autoimmune Diseases","quote":"Vasoactive intestinal peptide (VIP) is the paradigm of an endogenous neuropeptide produced during autoimmune responses and processes of systemic and local inflammation.","summary":"Review on VIP in inflammatory diseases.","claim_ids":["c4"],"link_status":"ok","quote_status":"verified","hash":"584a37b8f921aa3332ddc16f184f31edfadca3a5d0e91c7edbdf37eedc6b9cfe"},{"id":"web:1","type":"medical","url":"https://www.hopkinsarthritis.org/arthritis-news/vasoactive-intestinal-peptide-vip-prevents-experimental-arthritis-news-summary-from-johns-hopkins-arthritis/","title":"Vasoactive intestinal peptide (VIP) prevents experimental arthritis","quote":"VIP is a neuropeptide that has anti-inflammatory and immuno-modulatory properties. Its ability to suppress and prevent experimentally induced arthritis was reported by Delgado et al in Nature Medicine 7:563, 2001.","summary":"Summary of mouse CIA model results.","claim_ids":["c2"],"link_status":"timeout","quote_status":"unverified","hash":"b1039aacfd953a9ed1385e749c53eaa180e89bb249ae16e9d9d6a1bbec641e3b"},{"id":"web:36","type":"pubmed","url":"https://www.nature.com/articles/s41598-018-20400-6","title":"Vasoactive intestinal peptide gene polymorphisms... predict treatment requirements in early rheumatoid arthritis","quote":"We concluded that the identification of polymorphisms associated with VIP serum levels would complement the clinical assessment of the disease severity in rheumatoid arthritis patients.","summary":"Human study on VIP levels and RA outcomes.","claim_ids":["c3"],"link_status":"timeout","quote_status":"unverified","hash":"e68986c867320341cddfb90eb0fd7969a11ce3fa1ca983832dafe1849f045ed5"}],"anecdotal_sources":[],"scientific_sources":[{"id":"web:0","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6982157/","title":"A Clinical Approach for the Use of VIP Axis in Inflammatory and Autoimmune Diseases","quote":"Vasoactive intestinal peptide (VIP) is the paradigm of an endogenous neuropeptide produced during autoimmune responses and processes of systemic and local inflammation.","summary":"Review on VIP in inflammatory diseases.","claim_ids":["c4"],"link_status":"ok","quote_status":"verified","hash":"584a37b8f921aa3332ddc16f184f31edfadca3a5d0e91c7edbdf37eedc6b9cfe"},{"id":"web:1","type":"medical","url":"https://www.hopkinsarthritis.org/arthritis-news/vasoactive-intestinal-peptide-vip-prevents-experimental-arthritis-news-summary-from-johns-hopkins-arthritis/","title":"Vasoactive intestinal peptide (VIP) prevents experimental arthritis","quote":"VIP is a neuropeptide that has anti-inflammatory and immuno-modulatory properties. Its ability to suppress and prevent experimentally induced arthritis was reported by Delgado et al in Nature Medicine 7:563, 2001.","summary":"Summary of mouse CIA model results.","claim_ids":["c2"],"link_status":"timeout","quote_status":"unverified","hash":"b1039aacfd953a9ed1385e749c53eaa180e89bb249ae16e9d9d6a1bbec641e3b"},{"id":"web:36","type":"pubmed","url":"https://www.nature.com/articles/s41598-018-20400-6","title":"Vasoactive intestinal peptide gene polymorphisms... predict treatment requirements in early rheumatoid arthritis","quote":"We concluded that the identification of polymorphisms associated with VIP serum levels would complement the clinical assessment of the disease severity in rheumatoid arthritis patients.","summary":"Human study on VIP levels and RA outcomes.","claim_ids":["c3"],"link_status":"timeout","quote_status":"unverified","hash":"e68986c867320341cddfb90eb0fd7969a11ce3fa1ca983832dafe1849f045ed5"}],"user_reports":[],"related_articles":[],"question_graph":{"slug":"vip-plantar-fasciitis","questions":[],"evidence":[],"edges":[],"counts":{"questions":0,"evidence":0,"edges":0}},"honesty":{"active_claims":4,"retracted_claims":0,"cut_claims":0,"challenges":0,"scrub_events":0,"note":"Retracted/cut claims stay on ledger but are excluded from ask unless ?include_inactive=1"},"counts":{"claims":4,"claims_total":4,"sources":3,"anecdotal":0,"scientific":3,"user_reports":0,"questions":0,"evidence_ingests":0}}